Alzheimer dementia
Clinical trials for Alzheimer dementia explained in plain language.
Never miss a new study
Get alerted when new Alzheimer dementia trials appear
Sign up with your email to follow new studies for Alzheimer dementia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a natural compound slow Alzheimer's decline?
Disease control Recruiting nowThis trial is testing whether huperzine A, given as a controlled-release tablet, can improve thinking and daily living skills in people with mild-to-moderate Alzheimer's dementia. Participants will receive either huperzine A, a placebo, or an existing Alzheimer's drug (donepezil)…
Matched conditions: ALZHEIMER DEMENTIA
Phase 2/3 • Sponsor: Wanbangde Pharmaceutical Group Co., LTD • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could tiny doses of radiation slow Alzheimer's? a new trial investigates
Disease control Recruiting nowThis study tests whether very low doses of radiation delivered to the whole brain are safe and can help preserve thinking and memory in people with Alzheimer's disease or certain dementias with inflammation. Participants receive an initial course of 10 radiation sessions, followe…
Matched conditions: ALZHEIMER DEMENTIA
Phase 1/2 • Sponsor: Evan Thomas • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could a Vaccine-Like shot slow Alzheimer's? new trial launches
Disease control Recruiting nowThis early-stage trial tests a drug called CpG1018, which aims to stimulate the immune system to fight Alzheimer's disease. It involves 18 people with mild cognitive impairment or mild Alzheimer's. The main goal is to check safety, not yet to see if it works.
Matched conditions: ALZHEIMER DEMENTIA
Phase 1 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Blood test may unmask Alzheimer's during hospital stays
Diagnosis Recruiting nowThis study is testing whether a blood test (Quest AD-Detect) can help doctors identify Alzheimer's disease earlier in patients aged 60-90 who are hospitalized with confusion or delirium. The test looks for a protein linked to Alzheimer's. Patients with positive results will get f…
Matched conditions: ALZHEIMER DEMENTIA
Sponsor: Covenant Health, US • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
Hope for down syndrome: drug may stop Alzheimer's seizures
Prevention Recruiting nowThis study tests if the drug levetiracetam can prevent epileptic seizures in 120 adults over 40 with Down syndrome and Alzheimer's disease. Participants will receive either the drug or a placebo for 96 weeks. The goal is to see if the drug can stop seizures and possibly slow brai…
Matched conditions: ALZHEIMER DEMENTIA
Phase 3 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC
-
Can a brain ZAP and a common drug beat Alzheimer's apathy?
Symptom relief Recruiting nowThis small study tests whether combining methylphenidate (a drug already used for apathy) with a non-invasive brain stimulation technique called iTBS can reduce apathy in people with Alzheimer's or mixed dementia. The trial will include 12 participants who have significant apathy…
Matched conditions: ALZHEIMER DEMENTIA
Phase 2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Could a breath test reveal Parkinson's risk?
Knowledge-focused Recruiting nowThis study explores whether methane gas produced by gut microbes is linked to the progression of Parkinson's disease and related conditions like dementia. Researchers will measure breath methane levels in 200 adults—including those with Parkinson's, those at high risk (REM sleep …
Matched conditions: ALZHEIMER DEMENTIA
Sponsor: University of Cambridge • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC